Fifth Third Bancorp
VRNA

Fifth Third Bancorp’s Verona Pharma VRNA Stock Holding History

Fifth Third Bancorp’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000
Closed -$10K – 2762
2022
Q3 		$10K Hold
1,000
– – ﹤0.01% 1956
2022
Q2 		$4K Hold
1,000
– – ﹤0.01% 2317
2022
Q1 		$5K Hold
1,000
– – ﹤0.01% 2333
2021
Q4 		$7K Hold
1,000
– – ﹤0.01% 2247
2021
Q3 		$5K Hold
1,000
– – ﹤0.01% 2227
2021
Q2 		$7K Hold
1,000
– – ﹤0.01% 2140
2021
Q1 		$8K Buy
+1,000
New +$8.3K ﹤0.01% 2084

Other funds holding VRNA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return